Sham TMS: Clinical Trials

5 trials of Sham TMS, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 2 recruiting, 1 unknown. 5 Phase 2, 2 Phase 3, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 2, Recruiting 2, Unknown 1
Phase 32Completed 1, Recruiting 1
Phase 11Recruiting 1

Follow Sham TMS: new trials by email Literature Review of Sham TMS trials Research Report on Sham TMS

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Robotic Transcranial Magnetic Stimulation for Treatment Resistant Depression: The SPARC-TMS Trial
Neuronavigated robotic-enabled TMS, NRX-101, Sham TMS - Treatment Resistant Depression, Treatment Resistant Depression (TRD)
Phase 2 / Phase 3RecruitingNeuroRx, Inc.2402026-12-012026-10-21
Accelerated rTMS vs. Sham for Stroke Apathy
MagVenture MagPro Transcranial Magnetic Stimulation (TMS) System (Active), MagVenture MagPro Transcranial Magnetic Stimulation (TMS) System (Sham), Brainsight Neuronavigation System - Apathy, Stroke
Phase 1 / Phase 2RecruitingMedical University of South Carolina402025-08-082026-07-08
Transcranial Magnetic Stimulation and Constraint Induced Language Therapy for Chronic Aphasia
Active TMS, Sham TMS, CILT - Aphasia
Phase 2CompletedH. Branch Coslett862019-03-282025-10-14
Deep High-Frequency Repetitive Transcranial Magnetic Stimulation for Smoking Cessation
High frequency TMS, Sham TMS, Low frequency TMS - Chronic Obstructive Pulmonary Disease, Smoking
Phase 2 / Phase 3CompletedBeerYaakov Mental Health Center1152009-10-012013-12-20
rTMS in Elderly Depressed:Neuronavegated Study
Transcranial Magnetic Stimulation, Repetitive Transcranial Magnetic Stimulation - DEPRESSION
Phase 2UnknownUniversity of Sao Paulo General Hospital402009-08-012011-06-30

Conditions studied

Depression (3)  ·  Aphasia (1)  ·  Depressive Disorder, Treatment-Resistant (1)  ·  Ischemia (1)  ·  Lethargy (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Smoking (1)  ·  Stroke (1)

Sponsors

BeerYaakov Mental Health Center (1)  ·  H. Branch Coslett (1)  ·  Medical University of South Carolina (1)  ·  NeuroRx, Inc. (1)  ·  University of Sao Paulo General Hospital (1)

Countries

United States (3)  ·  Brazil (1)  ·  Israel (1)

Top investigators

Bianca B. Bellini (1)  ·  H. Branch Coslett, MD (1)  ·  Jonathan Javitt, MD, MPH (1)  ·  Joshua Brown, MD, PhD (1)  ·  Kevin Caulfield, PhD (1)  ·  Limor Dinur Klein (1)  ·  Lisa McTeague, PhD (1)  ·  Oded Rosenberg, M.D. (1)  ·  Parneet Grewal, PhD (1)

Results publications

PMID 25038985

NIH funding

R01DC016800 (1)